5篇
您的检索式：作者名="Hanguang Hu"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020显示文摘Colorectal cancer(CRC) is one of the major cancers threatening life and health of Chinese residents. According to the latest data released by the National Cancer Center in2015(1), there were 387,000 new cases and 187,100 deaths of CRC in China, accounting for 9.87% and 8.01% of all malignancies. The first version of the Chinese Society of Clinical Oncology(CSCO) guidelines was released in April2017, and has been updated annually based on the latest clinical research data and the availability of new drugs(2-4). Here, we present the main updates of the 2021 version compared to 2020 version. | Caixia Dong Yuwei Ding Shanshan Weng Guichao Li Yanqing Huang Hanguang Hu Zhen Zhang Suzhan Zhang Ying Yuan | 2021 | Chinese Journal of Cancer Research2021，33，3： | 19 |
| 2 | CSCO guidelines for colorectal cancer version 2022:Updates and discussions显示文摘Colorectal cancer(CRC) is the third most common cancer worldwide and the second most common in tumor-related mortality by Global Cancer Statistics 2020(1). Recent data show that the incidence and mortality of CRC in China are increasing(2-4), with the number of new cases and deaths reaching 607,900 and 261,777 in 2019. | Zhijun Yuan Shanshan Weng Chenyang Ye Hanguang Hu Suzhan Zhang Ying Yuan | 2022 | Chinese Journal of Cancer Research2022，34，2： | 16 |
| 3 | CSCO guidelines for colorectal cancer version 2023:Updates and insights显示文摘Colorectal cancer(CRC)is the second most common cancer and the most common type of gastrointestinal cancer with rapidly increasing incidence and mortality in China(1,2).Since the first edition of the Chinese Society of Clinical Oncology(CSCO)guideline was published in2017,the guideline has been updated annually according to the latest results of clinical research at home and abroad,the accessibility of drugs and the opinions of CSCO experts(3-7). | Mi Mi Shanshan Weng Ziheng Xu Hanguang Hu Yi Wang Ying Yuan | 2023 | Chinese Journal of Cancer Research2023，35，3： | 2 |
| 4 | Osteopontin - en- hanced hepatic metastasis of colorectal cancer cells 显示文摘 | Jianjin Huang Chi Pan Hanguang Hu | 2012 | PLoS 0ne2012，7，47： | 1 |
| 5 | Circulating tumor DNA analysis:potential to revise adjuvant therapy for stage II colorectal cancer显示文摘In the DYNAMIC multicenter phase 2 study recently published in The New England Journal of Medicine,Tie J.et al.demonstrated that a novel circulating tumor DNA(ctDNA)-guided regimen reduced the use of adjuvant chemotherapy without sacrificing recurrence-free survival in patients with stage II colorectal cancer(CRC).1 This was the first reported prospective,randomized,controlled trial of ctDNA-based interventional adjuvant treatment for stage II CRC. | Ning Zhu Hanguang Hu Ying Yuan | 2022 | Signal Transduction and Targeted Therapy2022，7，10： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员